AERI

Aerie Pharmaceuticals Inc

Price:

15.25

USD

Volume:

1,206,402.00

United States | Pharmaceuticals

-124.25 %

Upside

As of 2024-06-15, the Fair Value of Aerie Pharmaceuticals Inc (AERI) is -3.70 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.25 USD, the upside of Aerie Pharmaceuticals Inc is -124.25%.

Note: valuation result may not be accurate due to the company's negative EPS.

15.25 USD

Stock Price

-3.70 USD

Fair Price

Peter Lynch's formula is:

Aerie Fair Value

= Earnings Growth Rate x TTM EPS
Aerie Fair Value

= 5.00 x -0.74
Aerie Fair Value

= -3.70
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |

Net income | -145.11 | -232.57 | -199.58 | -183.10 | -74.81 | -167.03 |

YoY growth | -46.49% | -60.27% | 14.18% | 8.26% | 59.14% | -5.03% |

Market Cap (mil) | 753.62 |

P/E | |

Forward P/E |

EPS | -0.74 |

Avg earnings growth rate | -5.03% |

TTM earnings | -36.56 |